Actively Recruiting
Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer
Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2024-04-26
120
Participants Needed
2
Research Sites
248 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This multicenter, prospective observational cohort study has the potential to optimize individualized chemoradiotherapy regimen for early-stage esophageal cancer patients who have received endoscopic submucosal dissection.
CONDITIONS
Official Title
Multicenter Cohort Study of ESD and Chemo-radiotherapy for High-risk Early-stage Esophageal Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Esophageal cancer patients confirmed as pT1a-MM stage or pT1b stage after endoscopic submucosal dissection
- No definite contraindications for chemo-radiotherapy
- Signed informed consent
- Refused surgery after endoscopic submucosal dissection
You will not qualify if you...
- Severe heart, brain, lung disease or renal dysfunction
- Previous history of other malignancies
- Prior radiation or chemotherapy
- Researchers consider participation inappropriate
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
The Second Affiliated Hospital of Zhejiang University School of Medicine
Hangzhou, Zhejiang, China, 310000
Actively Recruiting
2
The Second Affiliated Hospital of Zhejiang University, School of Medicine
Hangzhou, China
Not Yet Recruiting
Research Team
J
Jing Xu, MD
CONTACT
Q
Qichun Wei, PHD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here